Dose: 50 mg
Single Dose: 50 (50)
Frequency: 24 hourly
Route: IV
Instructions: An initial dose of 70 mg by i.v.-infusion is given followed by 50 mg i.v. daily. If no response is seen or if inducers of caspofungin clearance are coadministered the daily dose may be increased to 70 mg i.v. An infusion should take approximately 1 hour.

. It is of Semi Synthetic origin. . The Molecular Weight of Caspofungin is 10931.31.

Caspofungin is contraindicated in conditions like Hypersensitivity to the drug,Breast feeding.

The symptomatic adverse reactions produced by Caspofungin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Fever, Abdominal pain, Rashes, Pruritus, Flushing, Nausea and vomiting, Hypersensitivity reactions, Injection-site reactions.

Caspofungin is primarily indicated in conditions like Gastric acid reduction during anaesthesia, Peritonitis.

No data regarding the interactions of Caspofungin was found.

Drug should not be given to patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Powder,Sol Store Below 30°C. Do not Freeze. Protect from Moisture and Heat.

Caspofungin should be used with caution in patients with hepatic impairment; pregnancy (avoid unless essential).